Mucinex® Nasal Spray

Mucinex® Nasal Spray

Drug Labeling and Warnings

Drug Details

k">

MUCINEX  FULL FORCE- oxymetazoline hydrochloride solution 
Reckitt Benckiser LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Mucinex®
Nasal Spray

Drug Facts

Active ingredient

Oxymetazoline hydrochloride 0.05%

Purpose

Nasal decongestant

Uses

  • temporarily relieves nasal congestion due to:
    • a cold
    • hay fever
    • upper respiratory allergies
  • promotes nasal and sinus drainage
  • temporarily relieves sinus congestion and pressure
  • helps clear nasal passages; shrinks swollen membranes

Warnings

Ask a doctor before use if you have

  • heart disease
  • thyroid disease
  • high blood pressure
  • diabetes
  • trouble urinating due to an enlarged prostate gland

When using this product

  • do not use more than directed
  • do not use for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen.
  • temporary discomfort such as burning, stinging, sneezing or an increase in nasal discharge may occur
  • use of this container by more than one person may spread infection

Stop use and ask a doctor if symptoms persist

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period.
  • children under 6 years of age: ask a doctor

Before using the first time, remove the protective cap from the tip and prime metered pump by depressing pump firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostril. Fully depress pump all the way down with a firm, even stroke and sniff deeply. Wipe nozzle clean after use.

Other information

  • store between 20-25°C (68-77°F)
  • retain carton for future reference on full labeling

Inactive ingredients

benzalkonium chloride, benzyl alcohol, edetate disodium, polyethylene glycol, povidone, propylene glycol, purified water, sodium phosphate dibasic, sodium phosphate monobasic

Questions?

1-866-MUCINEX (1-866-682-4639)

You may also report side effects to this phone number.

Dist. by: Reckitt Benckiser
Parsippany, NJ 07054-0224

PRINCIPAL DISPLAY PANEL - 30 mL Bottle Carton

33% MORE!

NDC: 63824-125-02

Mucinex®

NASAL SPRAY

Oxymetazoline HCl 0.05%
Nasal Decongestant

FULL
FORCE

CONCENTRATED VAPOR
TECHNOLOGY®

NEW
FORMULA

  • Powerful
    mucus-moving
    sensation
  • Fast Relief
    of sinus pressure
    & nasal congestion

12
HOUR

1 FL OZ (30 mL)

Principal Display Panel - 30 mL Carton
MUCINEX   FULL FORCE
oxymetazoline hydrochloride solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 63824-125
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Oxymetazoline Hydrochloride (UNII: K89MJ0S5VY) (Oxymetazoline - UNII:8VLN5B44ZY) Oxymetazoline Hydrochloride0.05 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
benzalkonium chloride (UNII: F5UM2KM3W7)  
benzyl alcohol (UNII: LKG8494WBH)  
edetate disodium (UNII: 7FLD91C86K)  
polyethylene glycols (UNII: 3WJQ0SDW1A)  
povidone (UNII: FZ989GH94E)  
propylene glycol (UNII: 6DC9Q167V3)  
water (UNII: 059QF0KO0R)  
sodium phosphate, dibasic (UNII: GR686LBA74)  
sodium phosphate, monobasic (UNII: 3980JIH2SW)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 63824-125-021 in 1 CARTON
130 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart34107/01/2011
Labeler - Reckitt Benckiser LLC (094405024)

Revised: 1/2012
 
Reckitt Benckiser LLC


© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.